Harbour BioMed and Evinova China Partner to Accelerate AI-Enabled Drug Development
Under the agreement, Harbour BioMed and Evinova China will combine their respective strengths to build an open ecosystem for AI-driven drug research and development.
AstraZeneca Group | 07/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy